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Replication Methods
Study Populations
The FHS Offspring cohort, which formed the first replication population, was initially recruited in 1971 and included 5,124 offspring of the FHS Original cohort. Detailed descriptions of the cohort have been published (1) . Among the 3,021 participants who attended the eighth exam cycle from 2005-2008, 2,836 provided peripheral whole blood samples and gave consent for genetic studies. DNA methylation measurements were conducted on two laboratory batches: batch 1, obtained from an ongoing case-control study of myocardial infarction (MI, n=576), and batch 2, which included the remainder of the cohort (n=2,270).
The ARIC Study, which formed the second replication population, is a prospective cohort study of cardiovascular disease risk in four U.S. communities (2) . Between 1987 and 1989, 7,082 men and 8,710 women aged 45-64 years were recruited from Forsyth County, North Carolina; Jackson, Mississippi (African Americans only); suburban Minneapolis, Minnesota; and Washington County, Maryland. Participants underwent a baseline clinical examination (Visit 1) and four subsequent follow-up clinical exams (Visits 2 -5). Methylation assays were performed on African Americans only, and the present study comprises a cross-sectional analysis of these data. DNA samples for the methylation analysis presented here had been collected at Visit 2. Measurements of BMI, WC, and other covariates also come from Visit 2 except as noted for physical activity.
Measurement of Obesity Traits and Covariates
In FHS, weight was measured to the nearest pound with the participant wearing only a gown without slippers or shoes, standing in the middle of the scale (Detecto Scale, Worcester Scale, Worcester, MA, USA) with weight equally distributed on both feet. Standing height was measured to the nearest ¼ inch, with the participant barefoot or wearing thin socks, using a vertical mounted stadiometer. BMI was calculated as described for GOLDN.
In the ARIC study, anthropometric measurements were taken with the subject wearing a scrub suit and no shoes, and BMI was calculated identically to GOLDN. WC was measured at the level of the umbilicus using a flexible tape. White blood cell (WBC) count was assessed by automated particle counters within 24 hours after venipuncture in local hospital hematology laboratory. The reliability coefficient for the WBC count measurement was greater than 0.96 (3). Questionnaires assessed education (coded as less than high school degree, high school degree or equivalent, and greater than high school degree), household income, cigarette smoking (coded as current/former/never), current alcohol consumption status (coded as current/former/never), and medical history. Level of physical activity was assessed at Visit 1 and Visit 3 using the leisure time activity index of the Baecke questionnaire, with scores from Visit 1 (baseline) used in this analysis (4) . Leisure time activity scores range in whole and half increments from 1 to 5, with values <2 indicative of physical inactivity (5) .
DNA Isolation and Bisulfite Conversion
In both replication cohorts, buffy coat preparations were obtained from the whole blood samples and genomic DNA was extracted using the Gentra Puregene Blood Kit (Qiagen, Venlo, Netherlands) according to the manufacturer's instructions. Subsequently, bisulfite conversion of 1 ug genomic DNA was performed using a protocol similar to GOLDN, except the ARIC study used the 96-well format version (EZ-96 DNA Methylation Kit; Zymo Research, Irvine, CA, USA). Before methylation analyses, bisulfite conversion efficiency was determined by PCR amplification of the converted DNA using Universal Methylated Human DNA Standard and Control Primers (Zymo Research, Irvine, CA, USA).
Normalization and Quality Control
Methylation measurements in the FHS cohort, also operationalized as β scores, underwent normalization within the two laboratory batches using the DASEN methodology implemented in the watermelon (http://bioconductor.org/packages/2.12/bioc/html/wateRmelon.html) R package (6), which includes background adjustment of the methylated and unmethylated intensities and quantile normalization of the methylated and unmethylated probes within the two types of probes technologies separately. For sample quality control, we excluded those with missing rate > 1% at detection P-value <0.01 (n=10 for batch 1 and n=35 for batch 2), poor matching to the 65 single nucleotide polymorphism (SNP) control probe locations (n=38 for batch 1 and n=41 for batch 2), and outliers by multi-dimensional scaling techniques (n=25 for batch 1 and n=48 for batch 2). For quality control at the probe level, we excluded those with missing rate >20% at detection P-value <0.01 (n=466 from batch #1 and n=366 from batch #2), as well as probes previously identified to map to multiple locations (7) or have an underlying SNP (minor allele frequency >5% in European ancestry 1000 genomes project data) at the CpG site or <=10 bp of the single base extension (n=42,251). We also excluded sex chromosomes. These procedures left 2,377 participants with phenotype data (n=442 for batch 1 and n=1,935 for batch 2) and 443,252 probes for analyses. Surrogate variable analysis (SVA) was used to adjust for unmeasured technical and batch effects, including cell count composition (8) . SVA retains the signal due to the primary variables of interest and determines singular vectors which occur greater than chance and represent the heterogeneity from unmeasured factors. SVAs were created within laboratory batches after removing the signals of interest from BMI, age, sex, smoking status, systolic blood pressure, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglycerides, fasting plasma glucose, and exam date. SVAs with a Pvalue < 0.01 were included in subsequent analysis (n=1 for batch 1 and n=4 for lab batch 2).
The analysis of the ARIC data used subset quantile within array normalization (SWAN) to normalize β scores (9). Positive and negative controls and sample replicates were included on each 96-well plate assayed. After exclusion of controls, replicates, and 22 samples that failed bisulfite conversion, a total of 2,950 study participants had epigenome-wide data available for further quality control analyses. We removed poor-quality samples with pass rate <99%, that is, if the sample had at least 1% of CpG sites with detection P-value > 0.01 or missing (n=32), indicative of lower DNA quality or incomplete bisulfite conversion, leaving n=2,918. At the target level, we flagged poor-quality CpG sites with average detection P-value > 0.01, and calculated the percentage of samples having detection P-value > 0.01 for each autosomal and X chromosome CpG site. Of the 2,918 samples with DNA methylation data after quality control, 50 were missing both concurrent body mass index and waist circumference. Removal of subjects without complete covariate data needed for confounder adjustment yielded a final data set of n=2,105 individuals for the BMI analysis and n=2,106 individuals for the WC analysis.
Statistical Analysis
During the replication stage in FHS, we fit linear mixed effect regression models with inversenormal transformation of the β score for the top 8 CpG probes as the outcome, BMI as the predictor, adjusted for age, sex, and SVAs as fixed effects and family structure as a random effect. Families were clustered based on sharing the same pedigree, which is a conservative approach to additionally account for shared environmental factors. We fit regression models to the two laboratory batches separately. Pooling data and adjusting for laboratory batch as opposed to meta-analysis of lab batches resulted in increases in the genomic control inflation factor from 1.035 to 1.07, suggesting residual confounding from batch effects and increases in false-positives, therefore we decided to report results from the two lab batches separately as well as in a meta-analysis with GOLDN and ARIC. Analyses without SVAs (not shown) resulted in increases in the inflation factor to 1.045. Robustness of primary models was examined by additionally adjusting for CVD and smoking status (not reported) due to the case-control nature of laboratory batch #1, which did not appreciably change the results. For replication in ARIC, crosssectional linear mixed models were tested with methylation β-values as the dependent variable, the chip (array) specified as a random effect and the following variables specified as fixed effects: standardized adiposity variable (BMI or WC, with mean= 0 and standard deviation (SD)=1), sex, age, study center, white blood cell count, education, household income, current cigarette smoking, current alcohol consumption, leisure time physical activity, and 10 principal components scores (PCs) from the Illumina Infinium HumanExome Beadchip genotype array to account for potential confounding by genetic ancestry (10) .
